Clinical Trial Update: Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women [Phase 4]

View source ↗

Summary

Phase 4 trial comparing immediate versus deferred isoniazid preventive therapy in HIV-infected pregnant women; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Tuberculosis | Phase 4 | Status: COMPLETED | Results posted: 2018-11-20